The Source • Fall 2010 • Issue 111

BCA Supports ODAC’s Call to Reject Avastin

by Kim Irish, BCA Program Manager In July 2010, the Oncologic Drugs Advisory Committee (ODAC) recommended that the Food and Drug Administration (FDA) withdraw approval of the drug Avastin as a treatment for advanced breast cancer. Breast Cancer Action supports this decision by ODAC because… Read More

From the Executive Director: So Much to Celebrate, and So Much Yet to Be Done

By Barbara Brenner I have written many articles for this newsletter over many years — first as a BCA volunteer member, then as a chair of the BCA board, and for the past 15 years, as BCA’s executive director. BCA celebrates 20 years of incredible… Read More

One Size Doesn’t Fit All: Latino/a Community Leaders Join Us

No hay talla única: Líderes de la comunidad latina y BCA Para Español, pulse aquí By Miriam Hidalgo One in five Latino/a deaths is caused by cancer. Lack of access to care increasingly threatens to increase the mortality rate in this community. Studies suggest an… Read More